Gene and cell therapy developers at ASGCT 2027
May 3–7, 2027 Philadelphia, PA ~8k attendees Website
3 gene and cell therapy developers are at ASGCT 2027 — 3 with a booth in the exhibit hall. 3 of them have their own page in this guide. As of Oct 29, 2026.
Showing 1–3 of 3 organizations
| Organization | ASGCT 2027 Attendance |
|---|---|
Gene therapy developer and Bayer subsidiary building AAV treatments for Parkinson's disease, heart failure and other rare and common conditions. | Booth Exhibiting at Booth 422 |
Vyriad Rochester, MN | |
Therapy developer engineering targeted virus platforms for in vivo gene therapy, genome editing and oncolytic virotherapy, with in-house preclinical and manufacturing capabilities. | Booth Exhibiting at Booth 319 |
SB Samyang Biopharm Seongnam, South Korea | |
Korean drugmaker of anticancer drugs and absorbable sutures that is developing SENS, a polymer and lipid nanoparticle system delivering siRNA and mRNA to selected tissues. | Booth Exhibiting at Booth 913 |
Find buyers from gene and cell therapy developers
Tell us what you sell and we’ll find the people at these gene and cell therapy developers most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse ASGCT 2027 by
Organization type
Focus area
Exhibit hall
Everyone
Not affiliated with the American Society of Gene & Cell Therapy. Organization details are derived from ASGCT’s published exhibitor list and each exhibitor’s own profile and website. Submit a correction